Aprameya Engineering Limited — Others, 08-05-2025: Statement of deviation(s) or variation(s) under Reg. 32

Aprameya Engineering Limited has announced a board meeting on 8th May, 2025, approving the financial results for the quarter and half-year ended March 31, 2025, along with the cash flow statement. Revenue for the year rose to Rs. 135.71 Cr, driven by medical equipment trading and turnkey projects, with profit before tax at Rs. 21.72 Cr and profit after tax at Rs. 16.12 Cr. Earnings per share increased to Rs. 9.27. Following its IPO raising Rs. 24.73 Cr, fully deployed for working capital, equity rose to Rs. 64.26 Cr. Operating cash flow was negative due to working capital changes. The board re-appointed its Joint Managing Directors and appointed new Company Secretaries. The auditor issued an unmodified opinion. The company is scaling up its healthcare infrastructure and equipment trading business post-IPO.